ConductScience.org, home

Gene · 55244

SLC47A1: solute carrier family 47 member 1

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. SLC47A1: solute carrier family 47 member 1. Genes, record 55244. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/55244

On this page

Gene

Symbol
SLC47A1
HGNC
Name
solute carrier family 47 member 1
HGNC
NCBI Gene ID
55244
NCBI Gene
HGNC ID
HGNC:25588
HGNC
Ensembl
ENSG00000142494
NCBI Gene
Aliases
FLJ10847, MATE1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q96FL8Multidrug and toxin extrusion protein 15704Ensembl, GeneID, HGNC

Source UniProt

Patents24

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1464726Q96FL8Espacenet
JP 2025529142 A2025-09-044246Q96FL8Espacenet
US 12371689 B22025-07-294246Q96FL8Espacenet
US 11446398 B22022-09-2081931Q96FL8Espacenet
US 11400116 B22022-08-024407Q96FL8Espacenet
JP 2022524081 A2022-04-27184902Q96FL8Espacenet
US 11078247 B22021-08-0310548Q96FL8Espacenet
JP 2020062004 A2020-04-23962Q96FL8Espacenet
JP 2019054813 A2019-04-11245161Q96FL8Espacenet
JP 2017121241 A2017-07-13245161Q96FL8Espacenet

1 to 10 of 24

See all 24 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants770

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleSLC47A1 papersNewest fiscal year
P30ES006694Southwest Environmental Health Sciences Center172025
P30DK026743UCSF Liver Center112025
P30CA008748Cancer Center Support Grant72025
U24CA247648The Chesapeake-Ohio Pharmacokinetics Core for The ETCTN72025
P30CA021765Cancer Center Support Grant (CCSG)62025
P30ES005022Rutgers Center for Environmental Exposure and Disease (CEED)62025
T32ES007148Training in Environmental Toxicology62025
T32HL007249Interdisciplinary Training in Cardiovascular Research62025
R35GM122576Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy52025
T32GM007546Clinical Pharmacology, Drug Action and Pharmacogenetics52025

1 to 10 of 770Source NIH's project files

See all 770 nih grants

Papers1,509

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Metformin Pharmacogenetics in Heart Failure Patients with Reduced Ejection Fraction: Impact on Metformin and Growth Differentiation Factor-15 Plasma Levels.Clin Pharmacokinet202642804152PubTator, text miningPubMed
Genetic Variants Involved in Metformin Pharmacokinetics in the Chilean Population.Genes (Basel)202642793008PubTator, text miningPubMed
Creatinine-Cystatin C Discrepancy and Renal Transporter Polymorphisms in Japanese Patients with Breast Cancer Receiving Abemaciclib.Clin Pharmacol Ther202642773505PubTator, text miningPubMed
In vitro assessments for pharmacokinetic drug-drug interaction potential of vornorexant, a novel dual orexin 1/2 receptor antagonist.Xenobiotica202642693680PubTator, text miningPubMed
Reconstitution and Transport Analysis of Multidrug Transporters.Methods Mol Biol202642681248PubTator, text miningPubMed
Berberine-Drug Interactions: Mechanisms, Clinical Relevance and Risk Stratification-A Narrative Review.Pharmaceuticals (Basel)202642653808PubTator, text miningPubMed
Population pharmacokinetic modeling of amisulpride drug interactions and a transporter binding analysis.Eur J Clin Pharmacol202642518010PubTator, text miningPubMed
Transporter gene variants influencing metformin pharmacokinetics and pharmacodynamics common in European populations: a pharmacogenetic narrative review.Front Pharmacol202642403712PubTator, text miningPubMed
Effects of Trimethoprim on Three Previously Proposed Putative Biomarkers for OCT2/MATE-Mediated Renal Drug-Drug Interactions in Healthy Volunteers.Clin Pharmacol Ther202642400553PubTator, text miningPubMed
Integrating CYP2D6 and MATE1 activities in drug-drug interaction assessment: Insights from newly developed antidepressant drug ammoxetine.J Pharmacol Exp Ther202642242161PubTator, text miningPubMed

1 to 10 of 1,509

See all 1,509 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/55244

GET https://conductscience.org/api/genes/v1/55244/patents?page=2